Kiniksa Pharmaceuticals International, plc — All Filings
702 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
15-15D
15-15D/A
3
4
424B4
424B5
5
8-A12B
8-K
8-K12B
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
PRE 14A
S-1
S-1/A
S-1MEF
S-3
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| S-3 | S-3 | 0001047469-19-003431 | Jun 3, 2019 | — |
| 4 | PRIMARY DOCUMENT | 0001638599-19-000562 | May 31, 2019 | May 29, 2019 |
| 4 | FORM 4 - | 0001179110-19-006867 | May 30, 2019 | May 29, 2019 |
| 4 | FORM 4 - | 0001179110-19-006866 | May 30, 2019 | May 29, 2019 |
| 4 | FORM 4 - | 0001179110-19-006868 | May 30, 2019 | May 29, 2019 |
| 4 | FORM 4 - | 0001179110-19-006869 | May 30, 2019 | May 29, 2019 |
| 10-Q | 10-Q | 0001558370-19-004284 | May 7, 2019 | Mar 31, 2019 |
| 8-K | 8-K | 0001104659-19-026215 | May 2, 2019 | — |
| DEF 14A | DEF 14A | 0001047469-19-002319 | Apr 17, 2019 | May 29, 2019 |
| DEFA14A | DEFA14A | 0001104659-19-021965 | Apr 17, 2019 | — |
| D | — | 0001567619-19-008415 | Apr 4, 2019 | — |
| 10-K | 10-K | 0001558370-19-001857 | Mar 12, 2019 | Dec 31, 2018 |
| 8-K | 8-K | 0001104659-19-013260 | Mar 7, 2019 | Mar 4, 2019 |
| 4 | 4 | 0001104659-19-013173 | Mar 6, 2019 | Mar 4, 2019 |
| 4 | 4 | 0001104659-19-013172 | Mar 6, 2019 | Mar 4, 2019 |
| 4 | 4 | 0001104659-19-013175 | Mar 6, 2019 | Mar 4, 2019 |
| 4 | 4 | 0001104659-19-013176 | Mar 6, 2019 | Mar 4, 2019 |
| 4 | 4 | 0001104659-19-013177 | Mar 6, 2019 | Mar 4, 2019 |
| 3 | 3 | 0001104659-19-013171 | Mar 6, 2019 | Mar 4, 2019 |
| 4 | 4 | 0001104659-19-013174 | Mar 6, 2019 | Mar 4, 2019 |
| SC 13G/A | — | 0000929638-19-000277 | Feb 14, 2019 | — |
| SC 13G | KINIKSA PHARMACEUTICALS, LTD. | 0000902664-19-001108 | Feb 14, 2019 | — |
| SC 13G | — | 0001172661-19-000534 | Feb 14, 2019 | — |
| SC 13G/A | — | 0001193805-19-000198 | Feb 12, 2019 | — |
| SC 13G | — | 0000932471-19-005539 | Feb 11, 2019 | — |
| 4 | PRIMARY DOCUMENT | 0001638599-19-000191 | Feb 6, 2019 | Feb 4, 2019 |
| SC 13D/A | SC 13D/A | 0001144204-19-005387 | Feb 6, 2019 | — |
| 8-K | 8-K | 0001104659-19-005120 | Feb 1, 2019 | Jan 28, 2019 |
| 424B4 | 424B4 | 0001047469-19-000331 | Feb 1, 2019 | — |
| FWP | FWP | 0001104659-19-004608 | Jan 31, 2019 | — |
| EFFECT | — | 9999999995-19-000039 | Jan 30, 2019 | — |
| S-1 | S-1 | 0001047469-19-000263 | Jan 28, 2019 | — |
| FWP | FWP | 0001104659-19-003712 | Jan 28, 2019 | — |
| 8-K | 8-K | 0001104659-19-003711 | Jan 28, 2019 | — |
| DRS | — | 0000912057-18-000516 | Dec 13, 2018 | — |
| 8-K | 8-K | 0001104659-18-067898 | Nov 13, 2018 | Nov 12, 2018 |
| 10-Q | 10-Q | 0001558370-18-008650 | Nov 6, 2018 | Sep 30, 2018 |
| 8-K | 8-K | 0001104659-18-065276 | Nov 1, 2018 | — |
| 4 | 4 | 0001104659-18-058110 | Sep 24, 2018 | Sep 20, 2018 |
| 4 | 4 | 0001104659-18-058111 | Sep 24, 2018 | Sep 20, 2018 |
| 4 | 4 | 0001104659-18-058107 | Sep 24, 2018 | Sep 20, 2018 |
| 4 | 4 | 0001104659-18-058108 | Sep 24, 2018 | Sep 20, 2018 |
| 4 | 4 | 0001104659-18-058109 | Sep 24, 2018 | Sep 20, 2018 |
| 8-K | 8-K | 0001104659-18-057064 | Sep 17, 2018 | — |
| 8-K | 8-K | 0001104659-18-056557 | Sep 13, 2018 | — |
| 10-Q | 10-Q | 0001104659-18-049660 | Aug 6, 2018 | Jun 30, 2018 |
| 8-K | 8-K | 0001104659-18-049650 | Aug 6, 2018 | — |
| SC 13G | SCHEDULE 13G | 0000897101-18-000644 | Jul 19, 2018 | — |
| SC 13G | — | 0000929638-18-000565 | Jun 4, 2018 | — |
| 4 | PRIMARY DOCUMENT | 0001638599-18-000584 | May 31, 2018 | Feb 9, 2018 |